ProQR Therapeutics (PRQR) Debt Ratio (2016 - 2026)

ProQR Therapeutics (PRQR) has reported Debt Ratio for 11 consecutive years, with 0.05 the latest figure, recorded in Q1 2026.

• Quarterly Debt Ratio rose 62.71% year-over-year to 0.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.05 (up 62.71% YoY) and the FY2025 annual result came in at 0.04, up 58.38% from the prior year.
• Debt Ratio climbed to 0.05 in Q1 2026 per PRQR's latest filing, from 0.04 in the prior quarter.
• Over the last five years, Debt Ratio for PRQR reached as high as 0.25 in Q2 2022 and fell as low as 0.03 in Q4 2024.
• A 5-year average of 0.06 and a median of 0.04 in 2022 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 120.11% — and 2023, when it slumped 82.57%.
• Year by year, Debt Ratio stood at 0.04 in 2022, then retreated by 21.24% to 0.03 in 2023, then slipped by 12.36% to 0.03 in 2024, then soared by 58.38% to 0.04 in 2025, then advanced by 15.56% to 0.05 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.05, 0.04, and 0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.